65162-023-09 · Lisdexamfetamine Dimesylate Capsule · Amneal Pharmaceuticals
What is the status for 65162-023-09 · Lisdexamfetamine Dimesylate Capsule · Amneal Pharmaceuticals?
For 65162-023-09, generic name is Lisdexamfetamine Dimesylate Capsule; manufacturer is Amneal Pharmaceuticals; status is Current; availability now is Available; initial posting date is 07/14/2023, recorded from its source on 2026-11-04.
"initial_posting_date": "07/14/2023", "package_ndc": "65162-023-09", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "866-525-7270", "availability": "Available"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 65162-023-09 verified
- Generic name
- Lisdexamfetamine Dimesylate Capsule verified
- Manufacturer
- Amneal Pharmaceuticals verified
- Status
- Current verified
- Availability now
- Available verified
- Initial posting date
- 07/14/2023 verified
- Last update date
- 10/06/2026 verified
- Days in shortage
- 1209 our reading
- Dosage form
- Capsule verified
- Therapeutic category
- Psychiatry verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"update_date": "10/06/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)", "company_name": "Amneal Pharmaceuticals", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000